Caroline Fabri Bittencourt Rodrigues
Papers
1
Total Citations
7
H-Index
1
About
Caroline Fabri Bittencourt Rodrigues is a researcher whose work bridges toxinology and molecular biochemistry, with a primary focus on snake venom inhibitors and their therapeutic potential. Her most-cited study, "BoaγPLI from Boa constrictor Blood is a Broad-Spectrum Inhibitor of Venom PLA2 Pathophysiological Actions" (2021, 7 citations), represents a significant contribution to the field. In this work, Rodrigues characterized a novel phospholipase A2 inhibitor derived from the blood of the Boa constrictor, demonstrating its ability to neutralize the harmful effects of multiple snake venoms. This discovery not only advances the understanding of natural resistance mechanisms in snakes but also opens avenues for developing more effective antivenom therapies. Her research is particularly impactful for its potential to address the limitations of current antivenoms, which often lack broad-spectrum efficacy. By identifying and characterizing this inhibitor, Rodrigues has provided a foundation for future studies aimed at creating universal or enhanced treatments for snakebite envenomation—a neglected tropical disease affecting hundreds of thousands annually. Her work exemplifies the intersection of evolutionary biology and applied pharmacology, offering hope for improved clinical outcomes in venomous snakebite management.
Research Focus
Key Achievements
Top Papers
- 1